Study of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell Lymphoma
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSD
- Dates
- study startedestimated completion
- Principal Investigator
- by Natalie Galanina (ucsd)
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UC Cancer
- Natalie Galanina (ucsd)
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Triphase Research and Development III Corp.
- ID
- NCT03682796
- Phase
- Phase 1
- Study Type
- Interventional
- Last Updated